NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Impact of Freeze-thaw Cycles and Storage Time on Plasma Samples Used in Mass Spectrometry Based Biomarker Discovery Projects.

Author(s): Mitchell BL, Yasui Y, Li CI, Fitzpatrick AL, Lampe PD

Publication: Cancer Inform, 2005, Vol. 1, Page 98-104

PubMed ID: 19305635 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effects of long-term storage of plasma specimens at -70 degrees C and freeze-thaw cycling on MALDI-TOF mass spectrometry data.

Conclusion of Paper

A majority of proteins and peptides were not significantly impacted by repeated freeze-thaw cycling, but 1% changed by at least 67%. No differences were seen in MALDI-TOF data between plasma specimens stored at -70 degrees C for 5 and 9 years.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of long-term storage of plasma specimens at -70 degrees C and freeze-thaw cycling on MALDI-TOF mass spectrometry data. Specimens were obtained from patients who were over 65 years of age.

    Summary of Findings:

    Repeated freeze-thaw cycling changed MALDI-TOF peak intensity with a wide range of values when compared to results after just one freeze-thaw cycle. However, median changes in peak intensity were only 1.7%, 2.4%, 3.5%, and 3.1% for 2, 3, 4, and 5 freeze-thaw cycles, respectively. The data suggests that peptides and proteins are generally stable with repeated freeze-thaw cycling of plasma but 1% changed by at least 67%. Consistent with protein degradation, peaks in the >10,000 mass/charge range (m/z) generally showed a reduction in intensity with freeze-thaw cycling, but peaks at 5000-10,000 m/z were increased by freeze-thaw cycling. No differences were seen in MALDI-TOF data between specimens stored at -70 degrees C for 5 and 9 years.

    Biospecimens
    Preservative Types
    • Frozen
    Diagnoses:
    • Normal
    Platform:
    AnalyteTechnology Platform
    Protein MALDI-TOF MS
    Peptide MALDI-TOF MS
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Storage Storage duration 5 y
    9 y
    Storage Storage temperature -70 degrees C
    Storage Freeze/thaw cycling 1 cycle
    2 cycles
    3 cycles
    4 cycles
    5 cycles

You Recently Viewed  

News and Announcements

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • Most Popular SOPs in March 2024

  • New SOPs Available

  • More...